Form 4 for PALI PALISADE BIO, INC.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001493152-26-006831 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-12 | PALI | Finley John David | CEO, CFO, Dir | S - Sale+OE | $1.75 | -3,896 | 27.4K | -12% | -$6,818 |
| D | 2026-02-13 | 2026-02-11 | PALI | Finley John David | CEO, CFO, Dir | M - OptEx | — | +13.3K | 31.2K | +74% | — |
| D | 2026-02-13 | 2026-02-11 | PALI | Finley John David | CEO, CFO, Dir | M - OptEx | $0.00 | -13.3K | 26.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | S | D | 3,896 | $1.75 | 27,353 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-11 | M | A | 13,333 | — | 31,249 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 11, 2025. (F2) Includes 4,444 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025. |
| 3 | Derivative | Restricted Stock Units | 2026-02-11 | M | D | 13,333 | $0.00 | 26,667 | D | — · — to — | 13,333 Common Stock | (F5) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F6) The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |